The main differences between connective tissue diseases-associated interstitial lung disease and idiopathic pulmonary fibrosis

Connective tissue diseases (CTD) can often cause respiratory system involvement. Interstitial lung disease (ILD) is an example of respiratory system involvement, which is the most frequent cause of mortality and morbidity, which challenges patients and their physicians in routine practice. Idiopathi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Turkish Society for Rheumatology 2021-04, Vol.13 (1), p.22-28
Hauptverfasser: Karataş, Ahmet, Öz, Burak, Pişkin Sağır, Rabia, Gür, Mustafa, Koca, Süleyman Serdar
Format: Artikel
Sprache:eng ; tur
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 28
container_issue 1
container_start_page 22
container_title Journal of Turkish Society for Rheumatology
container_volume 13
creator Karataş, Ahmet
Öz, Burak
Pişkin Sağır, Rabia
Gür, Mustafa
Koca, Süleyman Serdar
description Connective tissue diseases (CTD) can often cause respiratory system involvement. Interstitial lung disease (ILD) is an example of respiratory system involvement, which is the most frequent cause of mortality and morbidity, which challenges patients and their physicians in routine practice. Idiopathic pulmonary fibrosis (IPF) is another common cause of ILD. Similarities between CTD-ILD and IPF in terms of pathogenic, clinical and radiological findings complicate the distinction of the two diseases. However, the treatment of CTD-ILD and IPF is very different. Therefore, it is very important to distinguish both. ILD is grouped histopathologically and radiologically as usual interstitial pneumonia (UIP), non-specific interstitial pneumonia (NSIP), lymphocytic interstitial pneumonia (LIP) and organized pneumonia. Patients with CTD-ILD in the NSIP pattern have a better response to immunosuppressive therapy than patients with the UIP pattern. The effectiveness of antifibrotic therapy is more prominent in patients with the UIP pattern. While IPF is in the UIP pattern, CTD-ILD is often in the NSIP pattern. However, rheumatoid arthritis may be in the UIP pattern and Sjögren’s syndrome in the LIP pattern.
doi_str_mv 10.4274/raed.galenos.2021.39306
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2528897329</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2528897329</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1256-c8b9e96a6b38a2a31ec212a9332f0420d6e41500f2843da17318d04e404608433</originalsourceid><addsrcrecordid>eNo9kE1PwzAMhiMEEtPYbyAS55Z8NW2PaOJLmsRlnKM0dbdMXTriFMSF307HgJMt-5H96iHkmrNciVLdRgttvrE9hAFzwQTPZS2ZPiMzoQueCa35-X9fyEuyQNwxxkRVaM3YjHytt0D31gfa-q6DCMEB0gbSB0CgbggBXPLvQJNHHGGiECwCZhZxcN4maKkPCSImn7ztaT-GzR9FbZi2rR8ONm29o4ex3w_Bxk_a-SYO6PGKXHS2R1j81jl5fbhfL5-y1cvj8_JulTkuCp25qqmh1lY3srLCSg5OcGFrKUXHlGCtBsULxjpRKdlaXkpetUyBYkqzaSTn5OZ09xCHtxEwmd0wxjC9NKIQVVWXUtQTVZ4oN4XDCJ05RL-f8hrOzNG3Ofo2v77N0bf58S2_AebzeRg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2528897329</pqid></control><display><type>article</type><title>The main differences between connective tissue diseases-associated interstitial lung disease and idiopathic pulmonary fibrosis</title><source>DOAJ Directory of Open Access Journals</source><creator>Karataş, Ahmet ; Öz, Burak ; Pişkin Sağır, Rabia ; Gür, Mustafa ; Koca, Süleyman Serdar</creator><creatorcontrib>Karataş, Ahmet ; Öz, Burak ; Pişkin Sağır, Rabia ; Gür, Mustafa ; Koca, Süleyman Serdar</creatorcontrib><description>Connective tissue diseases (CTD) can often cause respiratory system involvement. Interstitial lung disease (ILD) is an example of respiratory system involvement, which is the most frequent cause of mortality and morbidity, which challenges patients and their physicians in routine practice. Idiopathic pulmonary fibrosis (IPF) is another common cause of ILD. Similarities between CTD-ILD and IPF in terms of pathogenic, clinical and radiological findings complicate the distinction of the two diseases. However, the treatment of CTD-ILD and IPF is very different. Therefore, it is very important to distinguish both. ILD is grouped histopathologically and radiologically as usual interstitial pneumonia (UIP), non-specific interstitial pneumonia (NSIP), lymphocytic interstitial pneumonia (LIP) and organized pneumonia. Patients with CTD-ILD in the NSIP pattern have a better response to immunosuppressive therapy than patients with the UIP pattern. The effectiveness of antifibrotic therapy is more prominent in patients with the UIP pattern. While IPF is in the UIP pattern, CTD-ILD is often in the NSIP pattern. However, rheumatoid arthritis may be in the UIP pattern and Sjögren’s syndrome in the LIP pattern.</description><identifier>ISSN: 2651-2653</identifier><identifier>EISSN: 2651-2661</identifier><identifier>DOI: 10.4274/raed.galenos.2021.39306</identifier><language>eng ; tur</language><publisher>Istanbul: Galenos Publishing House</publisher><subject>Connective tissue diseases ; Lung diseases ; Lupus ; Pulmonary fibrosis</subject><ispartof>Journal of Turkish Society for Rheumatology, 2021-04, Vol.13 (1), p.22-28</ispartof><rights>2021. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-1791-790X ; 0000-0002-6725-4182 ; 0000-0002-3841-5282 ; 0000-0003-4995-430X ; 0000-0001-9762-2401</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Karataş, Ahmet</creatorcontrib><creatorcontrib>Öz, Burak</creatorcontrib><creatorcontrib>Pişkin Sağır, Rabia</creatorcontrib><creatorcontrib>Gür, Mustafa</creatorcontrib><creatorcontrib>Koca, Süleyman Serdar</creatorcontrib><title>The main differences between connective tissue diseases-associated interstitial lung disease and idiopathic pulmonary fibrosis</title><title>Journal of Turkish Society for Rheumatology</title><description>Connective tissue diseases (CTD) can often cause respiratory system involvement. Interstitial lung disease (ILD) is an example of respiratory system involvement, which is the most frequent cause of mortality and morbidity, which challenges patients and their physicians in routine practice. Idiopathic pulmonary fibrosis (IPF) is another common cause of ILD. Similarities between CTD-ILD and IPF in terms of pathogenic, clinical and radiological findings complicate the distinction of the two diseases. However, the treatment of CTD-ILD and IPF is very different. Therefore, it is very important to distinguish both. ILD is grouped histopathologically and radiologically as usual interstitial pneumonia (UIP), non-specific interstitial pneumonia (NSIP), lymphocytic interstitial pneumonia (LIP) and organized pneumonia. Patients with CTD-ILD in the NSIP pattern have a better response to immunosuppressive therapy than patients with the UIP pattern. The effectiveness of antifibrotic therapy is more prominent in patients with the UIP pattern. While IPF is in the UIP pattern, CTD-ILD is often in the NSIP pattern. However, rheumatoid arthritis may be in the UIP pattern and Sjögren’s syndrome in the LIP pattern.</description><subject>Connective tissue diseases</subject><subject>Lung diseases</subject><subject>Lupus</subject><subject>Pulmonary fibrosis</subject><issn>2651-2653</issn><issn>2651-2661</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNo9kE1PwzAMhiMEEtPYbyAS55Z8NW2PaOJLmsRlnKM0dbdMXTriFMSF307HgJMt-5H96iHkmrNciVLdRgttvrE9hAFzwQTPZS2ZPiMzoQueCa35-X9fyEuyQNwxxkRVaM3YjHytt0D31gfa-q6DCMEB0gbSB0CgbggBXPLvQJNHHGGiECwCZhZxcN4maKkPCSImn7ztaT-GzR9FbZi2rR8ONm29o4ex3w_Bxk_a-SYO6PGKXHS2R1j81jl5fbhfL5-y1cvj8_JulTkuCp25qqmh1lY3srLCSg5OcGFrKUXHlGCtBsULxjpRKdlaXkpetUyBYkqzaSTn5OZ09xCHtxEwmd0wxjC9NKIQVVWXUtQTVZ4oN4XDCJ05RL-f8hrOzNG3Ofo2v77N0bf58S2_AebzeRg</recordid><startdate>20210401</startdate><enddate>20210401</enddate><creator>Karataş, Ahmet</creator><creator>Öz, Burak</creator><creator>Pişkin Sağır, Rabia</creator><creator>Gür, Mustafa</creator><creator>Koca, Süleyman Serdar</creator><general>Galenos Publishing House</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><orcidid>https://orcid.org/0000-0003-1791-790X</orcidid><orcidid>https://orcid.org/0000-0002-6725-4182</orcidid><orcidid>https://orcid.org/0000-0002-3841-5282</orcidid><orcidid>https://orcid.org/0000-0003-4995-430X</orcidid><orcidid>https://orcid.org/0000-0001-9762-2401</orcidid></search><sort><creationdate>20210401</creationdate><title>The main differences between connective tissue diseases-associated interstitial lung disease and idiopathic pulmonary fibrosis</title><author>Karataş, Ahmet ; Öz, Burak ; Pişkin Sağır, Rabia ; Gür, Mustafa ; Koca, Süleyman Serdar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1256-c8b9e96a6b38a2a31ec212a9332f0420d6e41500f2843da17318d04e404608433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; tur</language><creationdate>2021</creationdate><topic>Connective tissue diseases</topic><topic>Lung diseases</topic><topic>Lupus</topic><topic>Pulmonary fibrosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Karataş, Ahmet</creatorcontrib><creatorcontrib>Öz, Burak</creatorcontrib><creatorcontrib>Pişkin Sağır, Rabia</creatorcontrib><creatorcontrib>Gür, Mustafa</creatorcontrib><creatorcontrib>Koca, Süleyman Serdar</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Journal of Turkish Society for Rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Karataş, Ahmet</au><au>Öz, Burak</au><au>Pişkin Sağır, Rabia</au><au>Gür, Mustafa</au><au>Koca, Süleyman Serdar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The main differences between connective tissue diseases-associated interstitial lung disease and idiopathic pulmonary fibrosis</atitle><jtitle>Journal of Turkish Society for Rheumatology</jtitle><date>2021-04-01</date><risdate>2021</risdate><volume>13</volume><issue>1</issue><spage>22</spage><epage>28</epage><pages>22-28</pages><issn>2651-2653</issn><eissn>2651-2661</eissn><abstract>Connective tissue diseases (CTD) can often cause respiratory system involvement. Interstitial lung disease (ILD) is an example of respiratory system involvement, which is the most frequent cause of mortality and morbidity, which challenges patients and their physicians in routine practice. Idiopathic pulmonary fibrosis (IPF) is another common cause of ILD. Similarities between CTD-ILD and IPF in terms of pathogenic, clinical and radiological findings complicate the distinction of the two diseases. However, the treatment of CTD-ILD and IPF is very different. Therefore, it is very important to distinguish both. ILD is grouped histopathologically and radiologically as usual interstitial pneumonia (UIP), non-specific interstitial pneumonia (NSIP), lymphocytic interstitial pneumonia (LIP) and organized pneumonia. Patients with CTD-ILD in the NSIP pattern have a better response to immunosuppressive therapy than patients with the UIP pattern. The effectiveness of antifibrotic therapy is more prominent in patients with the UIP pattern. While IPF is in the UIP pattern, CTD-ILD is often in the NSIP pattern. However, rheumatoid arthritis may be in the UIP pattern and Sjögren’s syndrome in the LIP pattern.</abstract><cop>Istanbul</cop><pub>Galenos Publishing House</pub><doi>10.4274/raed.galenos.2021.39306</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-1791-790X</orcidid><orcidid>https://orcid.org/0000-0002-6725-4182</orcidid><orcidid>https://orcid.org/0000-0002-3841-5282</orcidid><orcidid>https://orcid.org/0000-0003-4995-430X</orcidid><orcidid>https://orcid.org/0000-0001-9762-2401</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2651-2653
ispartof Journal of Turkish Society for Rheumatology, 2021-04, Vol.13 (1), p.22-28
issn 2651-2653
2651-2661
language eng ; tur
recordid cdi_proquest_journals_2528897329
source DOAJ Directory of Open Access Journals
subjects Connective tissue diseases
Lung diseases
Lupus
Pulmonary fibrosis
title The main differences between connective tissue diseases-associated interstitial lung disease and idiopathic pulmonary fibrosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T03%3A46%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20main%20differences%20between%20connective%20tissue%20diseases-associated%20interstitial%20lung%20disease%20and%20idiopathic%20pulmonary%20fibrosis&rft.jtitle=Journal%20of%20Turkish%20Society%20for%20Rheumatology&rft.au=Karata%C5%9F,%20Ahmet&rft.date=2021-04-01&rft.volume=13&rft.issue=1&rft.spage=22&rft.epage=28&rft.pages=22-28&rft.issn=2651-2653&rft.eissn=2651-2661&rft_id=info:doi/10.4274/raed.galenos.2021.39306&rft_dat=%3Cproquest_cross%3E2528897329%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2528897329&rft_id=info:pmid/&rfr_iscdi=true